Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Pituitary
Published in: Pituitary 3-4/2005

01-12-2005

Hormonal Replacement in Patients with Brain Injury-Induced Hypopituitarism: Who, When and How to Treat?

Authors: Susie M. Estes, M.D., Randall J. Urban, M.D.

Published in: Pituitary | Issue 3-4/2005

Login to get access
Metadata
Title
Hormonal Replacement in Patients with Brain Injury-Induced Hypopituitarism: Who, When and How to Treat?
Authors
Susie M. Estes, M.D.
Randall J. Urban, M.D.
Publication date
01-12-2005
Publisher
Kluwer Academic Publishers
Published in
Pituitary / Issue 3-4/2005
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-006-6053-1

Other articles of this Issue 3-4/2005

Pituitary 3-4/2005 Go to the issue

OriginalPaper

GH Deficiency as The Most Common Pituitary Defect After TBI: Clinical Implications

OriginalPaper

Brain Injury and Hypopituitarism: The Historical Background

OriginalPaper

Hypopituitarism As a Consequence of Brain Tumours and Radiotherapy

OriginalPaper

Hypopituitarism and Growth Hormone Deficiency in Adult Subjects after Traumatic Brain Injury: Who and When to Test

OriginalPaper

Pituitary Function During Severe and Life-threatening Illnesses

OriginalPaper

Traumatic Brain Injury Induced Hypopituitarism: The Need and Hope of Rehabilitation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits